<DOC>
	<DOCNO>NCT00368693</DOCNO>
	<brief_summary>The purpose study test efficacy side effect , , Dermal - LSR combine standard treatment . We hypothesize treatment provide beneficial result diabetic patient suffer foot ulcer .</brief_summary>
	<brief_title>Efficacy Safety Study Dermal-Living Skin Replacement Treat Diabetic Foot Ulcers</brief_title>
	<detailed_description>This prospective , randomize , control , open-label , multi-center study test efficacy Dermal - Living Skin Replacement ( Dermal - LSR ) plus standard care treatment solely standard care treatment participant diabetic foot ulcer . The purpose study test Dermal - LSR combine standard treatment . We want see well work number type side effect , . We hope learn heal diabetic foot ulcer well . You : - interviewed examine - weekly clinic visit - blood drawn - ulcer photograph - wear walk boot reduce pressure ulcer</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Have Type I Type II diabetes Signed informed consent obtain subject legal guardian/representative prior first study intervention . Age ≥ 18 &lt; 85 year old time inform consent sign . Subjects diabetic ulcer lower extremity , ulcer follow characteristic : 1 . Fullthickness plantar ulcer ( fore mid foot ) ; 2 . Noninfected determined clinical assessment ; 3 . Neuropathic determine monofilament assessment ; 4 . Area ≥ 1.0 cm2 ≤ 25.0 cm2 postdebridement ; 5 . Has present least 8 week physician 's observation time enrollment ; 6 . Extends dermis without tendon , muscle , capsule bone exposure . Subjects one diabetic foot ulcer target limb . Subjects either insulindependent noninsulindependent diabetes mellitus ( Type I Type II , respectively ) HbA1C value range 6 % 12 % . The ulcer bed time enrollment must free necrotic infect soft bony tissue determine clinical examination ( evidence probe bone ) Xray film . Anklebrachial systolic pressure index 0.7 1.3 . If value &gt; 1.3 , transcutaneous partial pressure oxygen ( TcPO2 ) ≥ 40 mmHg OR toe pressure ≥ 50 mmHg must obtain subject eligible . Female subject must negative serum pregnancy test prior first treatment . Known suspected disease immune system currently investigation , Diabetes Mellitus . Active untreated malignancy active , uncontrolled connective tissue disease . Treatment immunosuppressive chemotherapeutic agent , radiotherapy corticosteroid less 30 day enrollment . Presence necrosis , purulence sinus tracts remove treatment . Has undergone revascularization procedure aim increase blood flow treatment target limb &lt; 4 week prior enrollment . Active febrile illness ( fever ≥ 38.0 ºC p.o. ) . Renal liver impairment indicate serum creatinine level liver function test three time higher normal value . Osteomyelitis diagnose expose bone radiological investigation . Subject active Charcot determine clinical examination ( new local pain , evidence swell warmth ) . Subjects refuse unable participate screening procedure , comply requirement study . Use investigational product time enrollment study . The use topical treatment , SOC , surface target ulcer time enrollment . Subjects enrol investigational clinical trial within 30 day screen visit . Currently pregnant lactating , plan pregnancy occur study period . Known allergic reaction , include dermatological hypersensitivity , study product component . Recent current history alcohol drug abuse . Subjects , opinion Investigator , represent poor medical , psychological psychiatric risk therapy investigational product would unwise .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>